Generic Name and Formulations:
Nitroglycerin 0.1mg/hr, 0.2mg/hr, 0.4mg/hr, 0.6mg/hr; transdermal patches.
Medicis Pharmaceuticals Corp
Indications for MINITRAN:
Prophylaxis of angina. Not for acute attacks.
Initially one 0.2mg/hr or 0.4mg/hr patch for 12–14hrs/day. Remove patch for 10–12hrs/day.
Acute or recent MI. Volume depletion. Hypotension. Heart failure. Hypertrophic cardiomyopathy. Reduce dose or discontinue if hypotension occurs. Remove before defibrillation or cardioversion. Pregnancy (Cat.C). Nursing mothers.
See Contraindications. Severe hypotension with sildenafil. Hypotension potentiated with alcohol, other vasodilators, calcium channel blockers.
Headache, dizziness, flushing, hypotension, increased angina, tachycardia, faintness, nausea, vomiting, rash.
Neurology Advisor Articles
- FDA Approves Aimovig for Migraine Prevention
- Prediction Algorithm Stratifies ICH Patients at Risk for Hematoma Expansion
- Sports-Related Concussion Outcomes Predicted With Serum Neurofilament Light
- FDA Fast-Tracks Treatment for Autism Spectrum Disorder
- Psychological Therapies May Help Older Adults With Chronic Pain
- Amyloid Positivity Increases Risk for Cognitive Impairment in Dementia-Free Patients
- Valproic Acid-Related Adverse Fetal Outcomes May Be Linked to Placental Effects
- Risk of Dementia Up for Older Adults With Lowest Wealth
- Language Used in Medical Record Can Affect Patient Care
- Mortality in Alzheimer Disease Not Strongly Associated With Antipsychotics